Leeds Teaching Hospitals NHS Trust has announced a strategic collaboration with Johnson & Johnson MedTech to drive healthcare innovation in West Yorkshire. This partnership combines the Trust’s clinical and health innovation expertise with Johnson & Johnson’s innovation capabilities, focusing on improving health outcomes and addressing health inequalities in Leeds and the wider region. They have signed a Memorandum of Understanding to collaborate on driving innovation, research and development (R&D), promoting skills and jobs in innovation, and increasing efficiency in the healthcare supply chain.
During an event at the Palace of Westminster, Dame Linda Pollard and Professor Phil Wood, along with Johnson & Johnson MedTech managing director, UK, Hugo Breda, officially announced the partnership. Their goal is to create a thriving health innovation ecosystem in Leeds with both local and global impacts. The collaboration will focus on:
- Driving Innovation and R&D: The partnership aims to bring forth new medical technologies that benefit all patients, particularly focusing on improving health equality.
- Promoting Skills and Jobs: They will nurture talent and skills for the future, contributing to job growth in the innovation sector.
- Efficiency in Healthcare: The collaboration seeks to enhance efficiency in the healthcare supply chain, with a focus on sustainability and climate benefits.
Leeds Teaching Hospitals and Johnson & Johnson MedTech Forge Partnership for Healthcare Innovation
Professor Phil Wood, CEO of Leeds Teaching Hospitals, emphasized the potential global impact of this collaboration. He highlighted the importance of embracing innovation to provide modern, efficient healthcare tailored to patients’ needs. The partnership with Johnson & Johnson MedTech aligns with this vision, combining clinical expertise with innovation capabilities.
Hugo Breda, Managing Director of Johnson & Johnson MedTech, UK, expressed the significance of this collaboration for healthcare in Leeds. He believes that by working together, they can drive innovation to address unmet healthcare needs and improve access to health services in West Yorkshire. Johnson & Johnson MedTech’s global research and development and manufacturing facility in Leeds will play a vital role in achieving these shared goals.
This partnership announcement comes on the heels of West Yorkshire being designated as the country’s third Investment Zone. This designation aims to accelerate digital and health tech innovation in the region, including the development of the Leeds Innovation Arc and the Innovation Village on the Leeds General Infirmary site.
Leeds Trust’s Innovation Pop-up Sparks Health Tech Revolution and Growth Prospects
The Innovation Pop-up, initiated by the Trust over two years ago and operating in 15 countries, has already fostered a vibrant community of health technology businesses and entrepreneurs. Their collaboration with hospital clinicians has transformed emerging technologies into practical healthcare solutions, benefiting not only Leeds but also a broader audience.
The Trust has also secured funding and approval to build a new Leeds Children’s Hospital, an adults’ hospital, and a large maternity center at the Leeds General Infirmary by 2030.
The development of the Innovation Village is expected to bring substantial economic benefits to Leeds, including job opportunities and new homes, contributing significantly to the city’s growth.
Resource: Medtechnews, November 27, 2023
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
